AbbVie, Inc.
Нет сделок
Корпоративные долговые ценные бумаги
Ниже приведён список облигаций AbbVie, Inc., отсортированных по доходности к погашению. Инвесторы часто выбирают облигации компании за их повышенную стабильность в периоды рыночной волатильности. Изучайте цены, доходности и другие показатели, чтобы найти надёжное вложение.
Инструмент | YTM % | Объём | Цена % | Купонная доходность % | Срок погашения | Задолженность | Номинал | Мин. деноминация | Эмитент |
|---|---|---|---|---|---|---|---|---|---|
| AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 7,00% | 26 K | 76,04% | 4,750% | 2045-03-15 | 53,51 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
| AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 6,40% | 12 K | 83,25% | 4,850% | 2044-06-15 | 65,23 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
| AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 6,38% | 124 K | 81,98% | 4,625% | 2042-10-01 | 67,49 M USD | 1 000,00 USD | 2 000,00 USD | Actavis, Inc. |
| AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 5,79% | 250 K | 91,22% | 4,550% | 2035-03-15 | 107,65 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
| 5,69% | 3,97 M | 96,89% | 5,500% | 2064-03-15 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,62% | 2,64 M | 97,24% | 5,400% | 2054-03-15 | 3 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,59% | 7,57 M | 100,25% | 5,600% | 2055-03-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,58% | 2,94 M | 82,78% | 4,250% | 2049-11-21 | 5,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,56% | 0 | 86,51% | 4,450% | 2046-05-14 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,56% | 6,5 M | 91,17% | 4,875% | 2048-11-14 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,53% | 0 | 90,15% | 4,700% | 2045-05-14 | 2,7 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,51% | 500 K | 91,05% | 4,750% | 2045-03-15 | 827,09 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,49% | 26 K | 90,47% | 3,200% | 2029-11-21 | 62,52 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,48% | 359 K | 92,82% | 4,850% | 2044-06-15 | 1,01 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,45% | 3,9 M | 99,02% | 5,350% | 2044-03-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,40% | 376 K | 91,68% | 4,625% | 2042-10-01 | 389,22 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,39% | 0 | 89,11% | 4,400% | 2042-11-06 | 2,6 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,14% | 6,71 M | 89,19% | 4,050% | 2039-11-21 | 4 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,85% | 0 | 95,53% | 4,300% | 2036-05-14 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,78% | 0 | 97,88% | 4,500% | 2035-05-14 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,77% | 317 K | 103,31% | 5,200% | 2035-03-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,76% | 12,9 M | 98,48% | 4,550% | 2035-03-15 | 1,68 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,65% | 5,01 M | 102,74% | 5,050% | 2034-03-15 | 3 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,19% | 1,27 M | 103,40% | 4,950% | 2031-03-15 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,09% | 5,16 M | 102,94% | 4,875% | 2030-03-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,97% | 7,55 M | 97,29% | 3,200% | 2029-11-21 | 5,44 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,92% | 17,19 M | 102,60% | 4,800% | 2029-03-15 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,86% | 0 | 99,83% | 3,200% | 2026-05-14 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,83% | 2,69 M | 101,11% | 4,250% | 2028-11-14 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,81% | 7,01 M | 101,06% | 4,800% | 2027-03-15 | 2,25 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,78% | 11,91 M | 99,36% | 2,950% | 2026-11-21 | 3,99 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,77% | 804 K | 101,68% | 4,650% | 2028-03-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,69% | 0 | 97,24% | 2,625% | 2028-11-15 | 72,11 M EUR | 1 000,00 EUR | 100 000,00 EUR | Allergan Funding SCS | |
| XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029 | 3,58% | 0 | 95,51% | 2,125% | 2029-06-01 | 36,46 M EUR | 1 000,00 EUR | 100 000,00 EUR | Allergan Funding SCS |
| 3,16% | 0 | 126,76% | 4,750% | 2045-03-15 | 5 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,13% | 0 | 128,71% | 4,850% | 2044-06-15 | 100 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,13% | 0 | 121,31% | 4,250% | 2049-11-21 | 4,95 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 2,98% | 0 | 90,94% | 1,250% | 2031-11-18 | 650 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
| 2,60% | 0 | 98,50% | 2,125% | 2029-06-01 | 506,09 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
| 2,57% | 0 | 123,74% | 4,550% | 2035-03-15 | 1 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 2,54% | 0 | 98,88% | 2,125% | 2028-11-17 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
| 2,48% | 0 | 100,39% | 2,625% | 2028-11-15 | 427,79 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
| 2,39% | 0 | 97,17% | 0,750% | 2027-11-18 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
| −5,92% | 0 | 98,80% | 2,950% | 2026-11-21 | 9,24 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| — | — | — | 4,400% | 2042-11-06 | 1,1 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |